Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Management of equine uveitis and cataracts Jonathan Pucket, DVM, MS, DACVO Outline • Equine uveitis – Current theories – Therapies – Prognosis • Equine cataracts – Causes – Therapy – Prognosis Uveal tract Choroid Iris Ciliary body www.nei.nih.gov Blood-ocular barriers • Blood-aqueous-barrier (BAB) – Tight junctions in iris and ciliary body • Blood-retinal-barrier – Tight junctions between retinal pigmented epithelial cells • These barriers limit the immune response to the internal aspect of the eye – Immune privileged site Ocular immunity • No direct contact between systemic immune system and inside the eye normally • Problems arise when local inflammation allows systemic immune system access • Have to control inflammation and restore barriers Uveitis • Inflammation of the uveal tract –Anterior • Iris and/or ciliary body –Posterior • Choroid • +/- retina –Panuveitis • Both Equine uveitis • Causes – Trauma – Reflex- Corneal disease – Immune mediated • Equine recurrent uveitis (ERU) – Neoplasia – Tooth root abscess – Infectious • Foals- sepsis • Rhodococcus • Salmonella • Leptospirosis • EVA • EIA • Hoof abscess Clinical signs of uveitis • Blepharospasm • Epiphora • Hyperemia of conjunctiva • Corneal edema • Corneal vascularization • Aqueous flare • • • • • • Fibrin Hyphema Miosis Synechia Cataract Iris color change Equine Recurrent Uveitis (ERU) • Documented, cyclical bouts of uveitis – Separated by periods of “remission” – At least 2 observed episodes • No set time between flares • Different “triggers” • Thought to be immune mediated – Leptospirosis? • Can affect anterior, posterior, or both • #1 cause of vision loss among horses ERU • Aka – Moon blindness – Periodic ophthalmia • Affects 2-25% of horses in USA ERU • Current theory – Initial inciting uveitis allows access of T-cells into eye – T-cells activate and proliferate – Attack leads to intraocular damage • During attack, T-cells find more antigens to become active against – New T-cells in circulation to cause another bout of inflammation Forms of ERU • Classic – Most common form, outward clinical signs – Attacks become increasingly severe • Insidious – No outward clinical signs – Gradual and cumulative destructive effect – Appaloosa and Draft breeds • Posterior – European horses, Draft breeds, and Warmbloods Appaloosa ERU • May have different pathogenesis • 8.3 X more likely than all other breeds combined • Typically no overt signs of disease until late • Horses with “Foundation-type” or “leopard” coat color more likely Therapies for ERU • Acute flare up – Attempt to determine cause (make sure not ulcer or stromal abscess as cause) – Fluorescein stain and tonometry – Topical anti-inflammatory drugs • Topical NSAID? • Topical Atropine (risk of colic) • Topical Steroid (risk if becomes ulcerated) – Systemic anti-inflammatory • Flunixin meglumine Therapies for ERU • Periodic flare ups –Manage as for acute flares • Topical anti-inflammatory • Topical atropine • Systemic flunixin meglumine Management practices • • • • Decrease dust Increase insect and rodent control Change bedding type Split up immunizations – Space ERU horse annual vaccines > 1 week apart – Lepto vaccine NOT recommended for ERU horses • Proper foot and dental care • Optimal deworming schedule Other therapies • Daily aspirin – No proven benefit at reducing flare ups • Antibiotics – Doxycycline and enrofloxacin • Only in cases of presumed leptospiral infections • Subconjunctival steroids – Extreme caution must be used – High risk of fungal keratitis – Cannot “remove” steroid if problem arises Other therapy • Cyclosporine A (CSA) – Absorption after topical application minimal – Weak anti-inflammatory effect • Strong immunosuppressant – Prevents activation of T lymphocytes and recurrence of uveitis Surgery • If flare ups are becoming more frequent/severe, can consider surgery • Uveitis must be “controlled” before surgery • CSA implant – NC State laboratory – Not FDA approved Long term with CSA implant • Horses had significantly fewer flare ups – Mean 0.05 flare ups/month – ~90% visual at 1-2 years after surgery – 78.8% visual at last follow up compared to 44% without CSA device – 12% of Appaloosas lost vision compared to 81% w/o • Replace device every 48 months – Reactive T-cells may undergo anergy leading to resolution of disease long term Long-term outcome after implantation of a suprachoroidal cyclosporine drug delivery device in horses with recurrent uveitis Brian C. Gilger,* David A. Wilkie,† Allison B. Clode,* Richard J. McMullen Jr.,* Mary E. Utter,‡ Andras M. Komaromy,‡ Dennis E. Brooks§ and Jacklin H. Salmon*. Vet Ophtho 2010 EQUINE CATARACTS Cataracts • Estimated 5-7% of all horses have cataracts • Stages (percent of lens involved) – Incipient- <15% – Immature- 16-99% – Mature- 100% – Hypermature- Resorbing lens Cataracts • Causes –Inflammation (#1 cause) • ERU –Hereditary/genetic –Trauma –Age related (Senile) Cataracts • Hereditary –Usually show very early in life (foals) –Certain breeds more common • Thoroughbreds • Morgan • Quarter horse • Rocky Mountain horses Treatment • Medical management – No preventative available – Topical atropine? – Topical NSAID • Flurbiprofen or Diclofenac • Cataract dissolving drops? • Surgery Selection of surgical candidates • Hereditary or congenital cataracts • Uveitis cataracts are poor candidates • Temperament – Must allow frequent exams and medication • Owner willing to return for follow-up exams – Owner must be dedicated Cataract surgery in horses • Visual compromise – Even with artificial lens, every horse undergoing surgery is considered visually compromised – Without lens they are very far-sighted • Risks of glaucoma, corneal ulcers, retinal detachment, and severe uveitis Cataract removal • Requires larger cataract surgery equipment – Not everyone has ability • Placement of subpalpebral lavage line (SPL) Pre-operative Diagnostics • • • • • CBC/Chem/Fibrinogen Thoracic radiographs in foals Ophthalmic exam Ocular ultrasound Electroretinogram (ERG) Post-operatively • Stall confinement for first 4 weeks • Slow tapering of topical medications • Rechecks – Evaluating for long term complications • Glaucoma • Retinal detachment • Uveitis Summary • Uveitis – Occurs frequently – Need to control quickly with medications – ERU can be difficult to control – CSA implant if repeated bouts • Cataracts – Uveitis cases not good candidates – Surgery can improve vision Questions?